Immutep Competitors and Similar CompaniesClear all
Numab's competitors and similar companies include Day One Biopharmaceuticals and Acrivon.
 Day One Biopharmaceuticals Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer. |  Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | ||
Founding Date | Founding Date 2011 | Founding Date 2018 | Founding Date 2018 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Wädenswil, CH HQ | Locations South San Francisco, US HQ | Locations Watertown, US HQ Lund, SE |
Employees | Employees 681% decrease | Employees 20 | Employees 415% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 256.1 m |
Financial | |||
Net income | Net income N/A | Net income ($107.3m) (FY, 2025) | Net income ($77.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 132.3m | Total funding raised $ 60m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Day One Biopharmaceuticals
HQ
South San Francisco, US
Employees
20
Day One Biopharmaceuticals is a company that develops drugs and therapies intended to find a cure for cancer.
View companyAcrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company